Our findings therefore suggest that both acetylation and RNA-binding ablation increase TDP-43 aggregation propensity and cause loss of free normal nuclear TDP-43 by promoting its mislocalisation and sequestration into pathological assemblies, thereby perpetuating TDP-43 dysfunction and aggregation in ALS and FTD. Here, TARDBP is linked to amyotrophic lateral sclerosis.